{
    "code": "02024443",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024443",
    "time": "2023-09-21 19:39:20",
    "許可證字號": "衛署藥輸字第024443號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/05\/12",
    "發證\/登錄日期": "95\/05\/12",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202444307",
    "中文品名": "老虎黴素凍晶注射劑50毫克",
    "英文品名": "Tygacil (Tigecycline) 50mg Lyophilized Powder",
    "適應症": "對Tigecycline具有感受性之細菌所引起之複雜性皮膚及皮膚結構感染、複雜性腹腔內感染症及社區感染性肺炎。",
    "劑型": "243凍晶注射劑",
    "包裝": "50毫克，每盒100支以下注射瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TIGECYCLINE",
    "限制項目": "02輸　入 57依本署七七公告於國內進行臨床試驗及生體可用率試驗且核定為新藥",
    "申請商名稱": "美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "WYETH LEDERLE S.R.L.",
            "製造廠廠址": "VIA FRANCO GORGONE, ZONA INDUSTRIALE, 95100 CATANIA (CT), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "製造、包裝"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "久裕企業股份有限公司(仿單置入作業)",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "30042000710 人用醫藥製劑，含四環素或其衍生物者Medicaments, containing tetracyclines or their derivatives, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812801200",
            "成分名稱": "TIGECYCLINE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "桔色結塊的凍晶粉末",
        "特殊劑型": "",
        "顏色": "桔色",
        "特殊氣味": "無",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "New label_Tygacil 202006-109-06-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024443&Seq=002&Type=10"
        },
        {
            "title": "Tygacil老虎黴素 MA no.024443實體 -104-09-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024443&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "#3. Tygacil LLD USPI 202007-3-111-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024443&Seq=025&Type=9"
        },
        {
            "title": "Tygacil_CTN_new address 202106-110-06-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024443&Seq=002&Type=8"
        },
        {
            "title": "Tygacil老虎黴素 MA no.024443外盒包裝-104-09-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024443&Seq=001&Type=8"
        }
    ]
}